TIME |
PROGRAMME DESCRIPTION |
14.00 - 22.00 |
Arrive: Hotel check-in and Meeting Registration |
20.00 - 22.00 |
Light snacks & Social Gathering |
TIME |
PROGRAMME DESCRIPTION |
8.00 - 9.00 |
Poster Setup |
9.00 - 9.15 |
Introduction |
9.15 - 11.00 |
Session 1: Novel approaches - Chairman: M. Roederer (US) |
| |
Design and use of conditional class I MHC ligands
(Ton Schumacher [Amsterdam, NL]) |
| |
Molecular and Functional Profiling of Immune Responses Using a pMHC Cellular Microarray
(Daniel Chen [Stanford, CA]) |
| |
A lymphocyte-antigen array approach for microdissection of the functional cellular immune response
(Giusi Li Pira [Genoa, I]) |
11.00 - 11.30 |
Break (coffee and tea at the exhibits) and poster viewing |
11.30 - 13.00 |
Session 2: Antigen-specific T Cells in HIV - Chairman: R. Koup (US) |
| |
New approaches for assessing antigen-specific T cell responses (V. Maino [US]) - Sponsored by BD Biosciences |
| |
Functional and physical effects of altered CD8 coreceptor engagement by peptide-MHC class I molecules
(David Price [Bethesda, MD]) |
| |
HIV-specific T cell responses in acute subtype C infection
(Clive Gray [Johannesburg, RSA]) |
| |
BD Biosciences Tutorial: Analysis of protein phosphorylation and cellular signaling events by flow cytometry. |
| |
Break (coffee and tea at the exhibits) and poster viewing |
17.30 - 19.00 |
Session 3: Parasites - Chairman: U. Krzych (US) |
| |
Analysis of the pathogenic T cell response in schistosomiasis
(Miguel Stadecker [Boston, MA]) |
| |
Role and antigen specificity of natural Treg during parasitic infections
(Yasmine Belkaid [Bethesda, MD]) |
| |
Protective immunity against malaria: parasites and proteins; antigen specificities and memory responses
(Ursula Krzych [Silver Spring, MD]) |
19.00 - 19.30 |
Break (coffee and tea at the exhibits) and poster viewing |
19.30 - 21.00 |
Session 4: Tuberculosis - Chairman: F. Kern (D) |
| |
Measuring antigen specific T cell responses in tuberculosis reveals 25 novel antigens encoded by genes of the dormancy regulon of Mycobacterium tuberculosis, as targets during latency
(Tom Ottenhoff [Leiden, NL]) |
| |
γδ-T lymphocytes and their role in immune response against Mycobacterium tuberculosis
(Francesco Dieli [Palermo, I]) |
| |
Effector mechanisms of TB-specific CD8+ T cells
(Steffen Stenger [Erlangen, D]) |
21.00 - 23.00 |
Poster Session I (odd-numbered posters)
Buffet Dinner
Exhibits |
TIME |
PROGRAMME DESCRIPTION |
8.30 - 9.15 |
Technical workshop I: MASIR: validation of phenotypic assays
(Mike Keeney [London, ON]) |
9.30 - 11.00 |
Session 5: Autoimmunity & Tumor Immunology |
| |
T-cell autoreactivity to islet antigens in type 1 diabetes
(Bart Roep [Leiden, NL]) |
| |
Identification of dominant T cell clones strongly responding to tumor antigens in melanoma patients
(D. Speiser [CH]) |
| |
TCR gene therapy of leukemia
(H. Stauss [UK]) |
11.00 - 11.30 |
Break (coffee and tea at the exhibits) and poster viewing |
11.30 - 13.00 |
Session 6: Antigen-Specific B & T cells - Chairman: T. Ottenhoff (NL) |
| |
Prompt and sustained protection against lethal viral disease induced by an improved adenoviral vaccine
(J. Christensen [DK]) - Sponsored by Dako |
| |
Antigen-specific B cells and plasma cells
(A. Radbruch [D]) |
| |
Poster P24: Decreased specific CD8+ T-cell cross-reactivity of antigen recognition following vaccination with Melan-A peptide
(V. Appay [CH]) |
| |
Poster P43: Detection and characterization of CD4+ viral, vaccine-induced and autoimmune-specific T cells using MHC-peptide arrays
(C. Walker [US]) |
13.00-15.00 |
Dako Tutorial: MHC Dextramers in practical use (how to optimize your results). |
16.00 - 17.00 |
Break (coffee and tea at the exhibits) and poster viewing |
17.00 - 19.30 |
Session 7: Antigen-specific T cells: SCT & infections |
| |
Immunotherapy with donor lymphocytes following allogeneic stem cell transplantation
(Shimon Slavin [Jerusalem, IL]) |
| |
Functional T cell immunity in allogeneic stem cell transplantation
(Krishna Komanduri [Houston, TX] |
| |
Poster P4: Characterization of CD8+ T cell responses to
dominant and subdominant epitopes in subtype
C HIV-1 infected individuals
(V. Morafo [ZA]) |
| |
Poster P61: Protection against Leishmania major following
vaccination with a recombinant adenovirus is
determined by the quality rather than the
magnitude of the Th1 response
(P. Darrah [US]) |
19.00 - 19.30 |
Break (coffee and tea at the exhibits) and poster viewing |
19.30 - 21.00 |
Session 8: Biology and specificity of NK and NKT lymphocytes - Chairman: L. Lanier (US) |
| |
Control of innate immunity by DAP12-associated immune receptor
(Lewis Lanier [San Francisco, CA]) |
| |
NK cells and tumor recognition
(Cristina Bottino [Genoa, I]) |
| |
NKT cells sustain B cell memory
(Sergio Abrignani [Milano, I]) |
21.00 - 23.00 |
Poster Session II (even-numbered posters)
Buffet Dinner
Exhibits |
TIME |
PROGRAMME DESCRIPTION |
8.30 - 9.15 |
Technical workshop II: MASIR: validation of functional assay
(Mario Roederer [Bethesda, MD]) & (Stephen De Rosa [US]) |
9.30 - 11.00 |
Session 9: Herpes viruses - Chairman: F. Manca (I) |
| |
T cell responses to virus infection : lessons from Epstein-Barr virus
(Alan Rickinson [Birmingham, UK]) |
| |
Immunogenic open reading frames of HCMV: analysis of T Cell responses in naturally infected humans
(Andrew Sylwester [Portland, OR])
|
| |
Poster P27: Differing phenotypic and functional profiles of
HIV- and CMV pp65-specific CD4+ T cells
( J. Casazza [US]) |
| |
Poster P31: Profound loss of IL2 secretion and proliferation
of HCV-specific T cells in HIV-1 co-infection
(V. Dutoit [CH]) |
11.00 - 11.30 |
Break (coffee and tea at the exhibits) and poster viewing |
11.30 - 13.00 |
Session 10: T-cell adoptive immunotherapy & New Technologies - Chairman: G. Li Pira (I) |
| |
Epstein-Barr virus
(Tanzina Haque [London, UK]) |
| |
Cell transfer therapy for patients with cancer
(Mark Dudley [Bethesda, MD]) |
| |
Poster P42: Monitoring T cell-mediated cytotoxicity using the fluorescent antigen-transfected target cellcytotoxic T lymphocyte assay
(C. van Baalen [NL]) |
| |
Poster P57: Primary human immune responses in vitro: A tool to screen immunogens and adjuvants for human use
(G. Lewis [US]) |
13.00 - 17.30 |
Break (coffee and tea at the exhibits) and poster viewing |
17.30 - 19.00 |
Session 11: MASIR and vaccination - chairman: A. Rickinson (UK) |
| |
The future of immunogenicity measurements for testing vaccine efficacy: quantity & quality
Mario Roederer [Bethesda, MD] |
| |
Toll-like receptor ligands influence the magnitude and quality of T cell responses
Bob Seder [Bethesda, MD] |
| |
Parsing the immunology of Tuberculosis in the context of vaccine design
Mark Doherty [Copenhagen, DK] |
| |
Unraveling immunologic memory with flow cytometry
Louis Picker [Portland, OR] |
20.15 - 23.00 |
Gala Dinner
Gather at Nomikos Conference center
buses to Santos Winery depart at 20:30 |
